Description

Tefibazumab CAS NO 521079-87-8 is a humanized monoclonal antibody designed for targeted therapeutic applications. This compound is of significant interest in the biopharmaceutical sector for its specific binding properties and potential in advanced treatment modalities. It is primarily utilized by research institutions, biotechnology firms, and pharmaceutical companies engaged in the development of novel immunotherapies and diagnostic agents.

Application

• Biopharmaceutical Research: A key reagent in preclinical studies for investigating novel therapeutic pathways and mechanisms of action.
• Immunotherapy Development: Serves as a foundational component in the research and formulation of targeted cancer therapies and other immune-mediated treatments.
• Diagnostic Assay Development: Used in the creation of sensitive and specific immunoassays for biomarker detection and disease monitoring.
• Antibody-Drug Conjugate (ADC) Platforms: Acts as a targeting moiety in the development of next-generation ADC constructs for precise drug delivery.
• Process Development & Scale-Up: Employed in downstream process optimization and manufacturing studies for biologic production.
• Quality Control & Reference Standards: Functions as a critical reference material for analytical method validation and batch release testing in GMP environments.

Basic Information

Product Name	Tefibazumab
CAS No.	521079-87-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Monoclonal Antibody Tefibazumab; Anti-Clumping Factor A Monoclonal Antibody; Aurexis; Humanized Monoclonal Antibody hCFA; Anti-CIfA Mab; KB-001; Anti-Staphylococcus aureus Monoclonal Antibody
EINECS	Contact for details

Quality Control

Our Tefibazumab is produced and tested under stringent quality management systems. Each batch undergoes comprehensive analytical characterization to ensure identity, purity, potency, and consistency, aligning with ICH guidelines for biopharmaceuticals. A comprehensive Certificate of Analysis (COA) detailing specifications such as purity (by SEC-HPLC and CE-SDS), endotoxin levels, sterility, and binding activity is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive); ensure containers are sealed under controlled humidity conditions upon opening.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (SEC-HPLC / CE-SDS)	Conforms to reference standard
Purity (Monomer by SEC-HPLC)	≥ 95.0%
Protein Concentration	As per COA
Endotoxin	< 1.0 EU/mg
Sterility	Sterile
Binding Activity (ELISA / SPR)	Conforms to reference standard

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.